Review



gitr agonist amg 228  (Amgen)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Amgen gitr agonist amg 228
    Gitr Agonist Amg 228, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gitr+agonist+amg+228/us11999802-3089-7-21?v=Amgen
    Average 90 stars, based on 1 article reviews
    gitr agonist amg 228 - by Bioz Stars, 2026-07
    90/100 stars

    Images



    Similar Products

    gitr agonist amg 228  (Amgen)
    90
    Amgen gitr agonist amg 228
    Gitr Agonist Amg 228, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gitr+agonist+amg+228/us11999802-3089-7-21?v=Amgen
    Average 90 stars, based on 1 article reviews
    gitr agonist amg 228 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    agonist anti-gitr mab amg 228  (Amgen)
    90
    Amgen agonist anti-gitr mab amg 228
    Ongoing clinical trials with costimulatory agonist monoclonal antibodies for cancer immunotherapy.
    Agonist Anti Gitr Mab Amg 228, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gitr+agonist+amg+228/pmc06487201-145-4-20?v=Amgen
    Average 90 stars, based on 1 article reviews
    agonist anti-gitr mab amg 228 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Ongoing clinical trials with costimulatory agonist monoclonal antibodies for cancer immunotherapy.

    Journal: International review of cell and molecular biology

    Article Title: Stimulating T cells against cancer with agonist immunostimulatory monoclonal antibodies

    doi: 10.1016/bs.ircmb.2018.07.003

    Figure Lengend Snippet: Ongoing clinical trials with costimulatory agonist monoclonal antibodies for cancer immunotherapy.

    Article Snippet: Subsequently, a number of agonist anti-GITR mAbs have entered phase I/II clinical trials including INCAGN01876 (Incyte), MK-4166 (Merck), AMG 228 (Amgen) and BMS-986156 (BMS).

    Techniques: Clinical Proteomics, Bioprocessing